<doc>
  <docmeta id="113s2504is">
    <bill congress="113" type="s" number="2504" version="is"/>
    <revision size="11567" annotations="0" status="complete" id="6" commit-time="2014-07-08T18:07:19Z" committer="mbohmer" doc="113s2504is/6.xml">
      <description>Edited via AKN</description>
    </revision>
  </docmeta>
  <bill bill-stage="Introduced-in-Senate" dms-id="A1" public-private="public">
	<metadata>
<dublinCore>
<dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">113 S2504 IS: Heroin and Prescription Opioid Abuse Prevention, Education, and Enforcement Act of 2014</dc:title>
<dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">U.S. Senate</dc:publisher>
<dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2014-06-19</dc:date>
<dc:format xmlns:dc="http://purl.org/dc/elements/1.1/">text/xml</dc:format>
<dc:language xmlns:dc="http://purl.org/dc/elements/1.1/">EN</dc:language>
<dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/">Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
</dublinCore>
</metadata>
<form>
		<distribution-code display="yes">II</distribution-code>
		<congress>113th CONGRESS</congress>
    <session>2d Session</session>
		<legis-num>S. 2504</legis-num>
		<current-chamber>IN THE SENATE OF THE UNITED STATES</current-chamber>
		<action>
			<action-date date="20140619">June 19, 2014</action-date>
			<action-desc>
        <sponsor name-id="S340">Ms. Ayotte</sponsor> (for herself and <cosponsor name-id="S356">Mr. Donnelly</cosponsor>) introduced the following bill; which was read twice and referred to the <committee-name committee-id="SSHR00">Committee on Health, Education, Labor, and Pensions</committee-name>
      </action-desc>
		</action>
		<legis-type>A BILL</legis-type>
		<official-title>To address prescription opioid and heroin abuse.</official-title>
	</form>
	<legis-body>
		<section id="S1" section-type="section-one">
      <enum>1.</enum>
      <header>Short title</header>
			<text display-inline="no-display-inline">This Act may be cited as the
		  <quote>
          <short-title>
            <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Heroin and Prescription Opioid Abuse Prevention, Education, and Enforcement Act of 2014" proposed="true">Heroin and Prescription Opioid Abuse Prevention, Education, and Enforcement Act of 2014</cato:entity-ref>
          </short-title>
        </quote>.</text>
		</section>
    <section id="idF6B336CB85B04080B063F639674E03DA">
      <enum>2.</enum>
      <header>Findings</header>
      <paragraph id="id799fef2a46a2427a86e42f84bfab4e4b">
        <enum>(1)</enum>
        <text>The <cato:entity xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="law-citation">
            <cato:entity-ref entity-type="act" value="Controlled Substances Act">Controlled Substances Act</cato:entity-ref> (<external-xref legal-doc="usc" parsable-cite="usc/21/801">
            <cato:entity-ref entity-type="uscode" value="usc/21/801/etseq">21 U.S.C. 801 et seq.</cato:entity-ref>
          </external-xref>)</cato:entity> declares that many controlled substances have
			 a useful and legitimate medical purpose and are necessary to maintain the
			 health and general welfare of the people of the United States.</text>
      </paragraph>
      <paragraph id="ide84ffaa1c57e4bab9fc7e9959b1cb706">
        <enum>(2)</enum>
        <text>Health care professionals, medical experts, researchers, and scientists have found pain to be a
			 major national health problem.</text>
      </paragraph>
      <paragraph id="id109fc5e6ee4f44ae815922759051e859">
        <enum>(3)</enum>
        <text>The responsible treatment of pain is a high priority for our Nation and the needs of individuals
			 with pain must be taken into careful consideration when taking steps to
			 prevent prescription drug misuse and abuse.</text>
      </paragraph>
      <paragraph id="id55c8f6d0fd3a4838b730e48454ec39f3">
        <enum>(4)</enum>
        <text>When no longer needed or wanted for legitimate pain management or health treatment, prescription
			 opioids are susceptible to diversion.	Prescription opioids also may be
			 abused by individuals who were not prescribed such drugs or misused by
			 individuals not taking such drugs as directed.</text>
      </paragraph>
      <paragraph id="idAC1353697FC94732A6D323092EEFC79B">
        <enum>(5)</enum>
        <text>Approximately 4 out of 5 new heroin users report that they became addicted to prescription
			 opioids before they used heroin for the first time.</text>
      </paragraph>
      <paragraph id="id67F77B940F784BB596C1B4741100673B">
        <enum>(6)</enum>
        <text>According to the National Institute on Drug Abuse, heroin attaches to the same brain cell receptors
			 as
			 prescription opioids.</text>
      </paragraph>
      <paragraph id="idA2B9440DA7BB4084ADB474C8F9E57A2A">
        <enum>(7)</enum>
        <text>The low cost and high purity of currently available heroin has contributed to an increase in heroin
			 use.</text>
      </paragraph>
      <paragraph id="id592a62703c16448bb8a37dd1fedd7881">
        <enum>(8)</enum>
        <text>More people are using heroin, and are using heroin at a younger age.  The National Survey on Drug
			 Use and Health  reports that new heroin users numbered 142,000 in 2010,
			 and increased to 178,000 in 2011. In 2011, the average age at first use
			 among heroin abusers between 12 and 49 years was 22.1 years.  In 2009, the
			 average age at first use among
			 heroin abusers between 12 and 49 years was 25.5 years.</text>
      </paragraph>
      <paragraph id="id1c0bc72f5a7c4897b40b36928469bf2d">
        <enum>(9)</enum>
        <text>According to the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-id="7500" entity-type="federal-body">Department of Health and Human Services</cato:entity-ref>, heroin use rose 79 percent nationwide
			 between 2007 and 2012.</text>
      </paragraph>
      <paragraph id="id9A94221687424F399A4199F92B03452E">
        <enum>(10)</enum>
        <text>Deaths from heroin overdose have significantly increased in communities across the United States.
			 According to the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-id="7523" entity-type="federal-body">Centers for Disease Control and Prevention</cato:entity-ref>, the number of
			 deaths involving heroin increased by 110 percent from 2006 to 2011.  From
			 2010 to 2011, the number of heroin deaths rose from 3,036 to 4,397.</text>
      </paragraph>
      <paragraph id="idF0072C9261094FD7B7B831F1D0143FAE">
        <enum>(11)</enum>
        <text>The Edward Byrne Memorial Justice Assistance Grant
Program is critical to fighting the prescription opioid abuse and heroin use epidemics, and should
			 be reauthorized and fully funded.</text>
      </paragraph>
    </section>
    <section id="id061F0FCB23FE4B6C82D290D269FA4E95">
      <enum>3.</enum>
      <header>Development of best prescribing practices</header>
      <subsection id="id1DB8AFA1D8EB4E3FB7F3F4C07FD763F1">
        <enum>(a)</enum>
        <header>Inter-Agency task force</header>
        <text display-inline="yes-display-inline">Not later than 120 days after the date of enactment of this Act, the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-id="7500" entity-type="federal-body">Secretary of Health and Human
			 Services</cato:entity-ref> (referred to in this section as the <quote>Secretary</quote>), in cooperation with the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-id="3600" entity-type="federal-body">Secretary of Veterans Affairs</cato:entity-ref>, the
			 <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-id="9700" entity-type="federal-body">Secretary of Defense</cato:entity-ref>, and the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-id="1524" entity-type="federal-body">Administrator of the Drug
			 Enforcement Administration</cato:entity-ref>, shall convene a <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" proposed="true" value="Pain Management Best Practices Inter-Agency Task Force">Pain Management Best Practices
			 Inter-Agency Task Force</cato:entity-ref> (referred to in this section as the <term>task force</term>).</text>
      </subsection>
      <subsection id="id6B3CE7B30AA24734819E750690110416">
        <enum>(b)</enum>
        <header>Membership</header>
        <text>The task force shall be comprised of—</text>
        <paragraph id="id26472ABD42EA4D1EA92911C6A359D96D">
          <enum>(1)</enum>
          <text>representatives of—</text>
          <subparagraph id="idB92DAA83988147E08DA7869510C0A065">
            <enum>(A)</enum>
            <text>the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-id="7500" entity-type="federal-body">Department of Health and Human Services</cato:entity-ref>;</text>
          </subparagraph>
          <subparagraph id="idD9EE5706BC0948EC835491614323E366">
            <enum>(B)</enum>
            <text>the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-id="3600" entity-type="federal-body">Department of Veterans Affairs</cato:entity-ref>;</text>
          </subparagraph>
          <subparagraph id="id83B4D7D6772648508EEF809674D4AC23">
            <enum>(C)</enum>
            <text>the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-id="9700" entity-type="federal-body">Department of Defense</cato:entity-ref>;</text>
          </subparagraph>
          <subparagraph id="idA277E7D498D248718F8F75B1F4CEB69F">
            <enum>(D)</enum>
            <text>the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-id="1524" entity-type="federal-body">Drug Enforcement Administration</cato:entity-ref>; and</text>
          </subparagraph>
          <subparagraph id="idBFEF9A28F13D42F68BA65D119DFE116B">
            <enum>(E)</enum>
            <text>the Institute of Medicine;</text>
          </subparagraph>
        </paragraph>
        <paragraph id="id31C83658DEAB406DBDF8EABCCCE7F9E8">
          <enum>(2)</enum>
          <text>the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-id="7529" entity-type="federal-body">Director of the National Institutes of Health</cato:entity-ref>;</text>
        </paragraph>
        <paragraph id="idE5F1D75ED2ED4D97B79842416AAC6598">
          <enum>(3)</enum>
          <text>physicians and non-physician prescribers;</text>
        </paragraph>
        <paragraph id="idC91040E17127454FAA8018D21396CD99">
          <enum>(4)</enum>
          <text>pharmacists;</text>
        </paragraph>
        <paragraph id="idFE7DF4AB1EC345C8A275FFC522BA74AD">
          <enum>(5)</enum>
          <text>experts in the fields of pain research and addiction research;</text>
        </paragraph>
        <paragraph id="id8373C06495824232B90DEAFA3AACF416">
          <enum>(6)</enum>
          <text>representatives of—</text>
          <subparagraph id="idD2B358B00ABE4110A2BE502289053EC5">
            <enum>(A)</enum>
            <text>pain management professional organizations;</text>
          </subparagraph>
          <subparagraph id="id495CE2AEACFE4958B376EB188E4002AA">
            <enum>(B)</enum>
            <text>the mental health treatment community; and</text>
          </subparagraph>
          <subparagraph id="id3FFB34330E07449AB034B181A1E42D40">
            <enum>(C)</enum>
            <text>pain advocacy groups; and</text>
          </subparagraph>
        </paragraph>
        <paragraph id="idB6E8806FC1144FF6A2326E7FC0C3DCB3">
          <enum>(7)</enum>
          <text>other stakeholders, as the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary</cato:entity-ref> determines appropriate.</text>
        </paragraph>
      </subsection>
      <subsection id="idA8748354C25D4BFBA724B3CD1B9D15B8">
        <enum>(c)</enum>
        <header>Duties</header>
        <text>The task force shall—</text>
        <paragraph id="idA63C2D62ECCF42E0A3D2208182FCA399">
          <enum>(1)</enum>
          <text>not later than 180 days after the date on which the task force is convened, develop best practices
			 for pain management and prescription pain medication prescribing
			 practices, taking into consideration—</text>
          <subparagraph id="idF1671EBB2DC34F559800DBF00184C3B3">
            <enum>(A)</enum>
            <text>existing pain management research;</text>
          </subparagraph>
          <subparagraph id="idF384E1FAC748471093FB63C352B5F1E1">
            <enum>(B)</enum>
            <text>recommendations from relevant conferences; and</text>
          </subparagraph>
          <subparagraph id="id586A3DB0075D40B78C2D22D483C132CD">
            <enum>(C)</enum>
            <text>ongoing efforts at the State and local levels and by medical professional organizations to develop
			 improved pain management strategies;</text>
          </subparagraph>
        </paragraph>
        <paragraph id="id4C8EAA26346447E184C59CD6430F22E3">
          <enum>(2)</enum>
          <text>solicit and take into consideration public comment on the practices developed under <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Heroin and Prescription Opioid Abuse Prevention, Education, and Enforcement Act of 2014/s:3/ss:c/p:1" proposed="true">paragraph (1)</cato:entity-ref>,
			 amending such best practices if appropriate; and</text>
        </paragraph>
        <paragraph id="id6BB44B36954248D0BD00D7573EA7F90E">
          <enum>(3)</enum>
          <text>develop a strategy for disseminating information about the
			 best practices developed under <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Heroin and Prescription Opioid Abuse Prevention, Education, and Enforcement Act of 2014/s:3/ss:c/p:1" proposed="true">paragraphs (1)</cato:entity-ref> and <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Heroin and Prescription Opioid Abuse Prevention, Education, and Enforcement Act of 2014/s:3/ss:c/p:2" proposed="true">(2)</cato:entity-ref> to prescribers,
			 pharmacists, State medical boards, and other 
			 parties, as the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary</cato:entity-ref> determines appropriate.</text>
        </paragraph>
      </subsection>
      <subsection commented="no" id="id4DF15AEE8B30460FA2E9A3E1BB68CDC8">
        <enum>(d)</enum>
        <header>Limitation</header>
        <text>The task force shall not have rulemaking authority.</text>
      </subsection>
      <subsection id="idA819166BC4C3401C961913A61896E8CC">
        <enum>(e)</enum>
        <header>Report</header>
        <text>Not later than 270 days after the date on which the task force is convened under <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Heroin and Prescription Opioid Abuse Prevention, Education, and Enforcement Act of 2014/s:3/ss:a" proposed="true">subsection (a)</cato:entity-ref>,
			 the task force shall submit to
			 <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="0001">Congress</cato:entity-ref> a report that includes—</text>
        <paragraph id="id7C7932BB92E54C75A122015A20C67DAC">
          <enum>(1)</enum>
          <text>the strategy for disseminating best practices developed under <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Heroin and Prescription Opioid Abuse Prevention, Education, and Enforcement Act of 2014/s:3/ss:c" proposed="true">subsection (c)</cato:entity-ref>;</text>
        </paragraph>
        <paragraph id="id8B85523F3FC84731B7F67F3059E4422D">
          <enum>(2)</enum>
          <text>the results of a feasibility study on
			 linking best practices developed under <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Heroin and Prescription Opioid Abuse Prevention, Education, and Enforcement Act of 2014/s:3/ss:c/p:1" proposed="true">paragraphs (1)</cato:entity-ref> and <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Heroin and Prescription Opioid Abuse Prevention, Education, and Enforcement Act of 2014/s:3/ss:c/p:2" proposed="true">(2) of
			 subsection (c)</cato:entity-ref> to receiving and
			 renewing registrations under <cato:entity xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="law-citation">
              <cato:entity-ref entity-type="act" value="Controlled Substances Act/s:303/ss:f">section 303(f) of the Controlled Substances
			 Act</cato:entity-ref> (<external-xref legal-doc="usc" parsable-cite="usc/21/823">
              <cato:entity-ref entity-type="uscode" value="usc/21/823/f">21 U.S.C. 823(f)</cato:entity-ref>
            </external-xref>)</cato:entity>; and</text>
        </paragraph>
        <paragraph id="id0BC207E8D025487791A31D46E34EE7A8">
          <enum>(3)</enum>
          <text>recommendations on how to apply such best practices to improve prescribing practices at medical
			 facilities of the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-id="3620" entity-type="federal-body">Veterans Health Administration</cato:entity-ref>.</text>
        </paragraph>
      </subsection>
    </section>
    <section id="id58BC7B63D4F545FCAFD24D376F9C3B6B">
      <enum>4.</enum>
      <header>Harold Rogers Prescription Drug Monitoring Program</header>
      <subsection id="id550A8DC025DD4BCC81BA8DFA45D0CFF7">
        <enum>(a)</enum>
        <header>Authorization of appropriations</header>
        <text>
          <cato:entity xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="auth-auth-approp">
            <cato:property name="purpose">To carry out the Harold Rogers Prescription Drug Monitoring Program established under the
			 <cato:entity entity-type="law-citation">
                <cato:entity-ref entity-type="act" value="Departments of Commerce, Justice, and State, the Judiciary, and Related Agencies Appropriations Act, 2002">Departments of Commerce, Justice, and State, the Judiciary, and Related
			 Agencies Appropriations Act, 2002</cato:entity-ref> (<external-xref legal-doc="public-law" parsable-cite="pl/107/77">
            <cato:entity-ref entity-type="public-law" value="public-law/107/77">Public Law 107–77</cato:entity-ref>
          </external-xref>; <cato:entity-ref entity-type="statute-at-large" value="statute-at-large/115/748">115 Stat. 748</cato:entity-ref>)</cato:entity>
            </cato:property>,
			 there is authorized to be appropriated <cato:funds-and-year amount="9000000" year="2015, 2016, 2017, 2018, 2019">$9,000,000 for each of fiscal years
			 2015 through 2019</cato:funds-and-year>.</cato:entity>
        </text>
      </subsection>
      <subsection id="id2DBABFDCA9DA4B8DBDC6EE0159450C2C">
        <enum>(b)</enum>
        <header>GAO report</header>
        <text>Not later than October 1, 2016, the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-id="0500" entity-type="federal-body">Comptroller General of the United States</cato:entity-ref> shall submit to
			 <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="0001">Congress</cato:entity-ref> a report on the effectiveness
			 of the Harold Rogers Prescription Drug Monitoring Program in reducing
			 prescription drug abuse, and, to the extent practicable, any corresponding
			 increase or decrease in the use of heroin.</text>
      </subsection>
    </section>
    <section id="id9745378078C6422B97641CCE69F63BE1">
      <enum>5.</enum>
      <header>Reauthorization of Byrne Justice Assistance Grant program</header>
      <text display-inline="no-display-inline">
        <cato:entity xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="law-citation">
          <cato:entity-ref entity-type="act" value="Omnibus Crime Control and Safe Streets Act of 1968/t:I/s:508">Section 508 of title I of the Omnibus Crime Control and Safe Streets Act of 1968</cato:entity-ref> (<external-xref legal-doc="usc" parsable-cite="usc/42/3758">
          <cato:entity-ref entity-type="uscode" value="usc/42/3758">42 U.S.C. 3758</cato:entity-ref>
        </external-xref>)</cato:entity>
			 is amended by striking <quote>2006 through 2012</quote> and inserting <quote>
          <cato:entity xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="auth-auth-approp">
            <cato:funds-and-year amount="1095000000" year="2015, 2016, 2017, 2018, 2019">2015 through 2019</cato:funds-and-year>
          </cato:entity>
        </quote>.</text>
    </section>
    <section id="id3042ED40E3F24AD4B83078638A480654">
      <enum>6.</enum>
      <header>Office of National Drug Control Policy</header>
      <subsection id="id0027F24AE1A54058AC3C203DC82F6B83">
        <enum>(a)</enum>
        <header>Update of plan To account for increased heroin use</header>
        <text>Not later than 180 days after the date of enactment of this Act, the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-id="1127" entity-type="federal-body">Director of the Office of
			 National Drug Control Policy</cato:entity-ref> shall revise the 2011 Prescription Drug Abuse
			 Prevention Plan to  reassess the approach under such plan to addressing
			 prescription drug abuse in light of an increase in heroin use, and to
			 outline actions or programs that can be carried out to reduce and prevent
			 such abuse.</text>
      </subsection>
      <subsection id="id2AC0C629764F49CBA6F35ABA72B008C3">
        <enum>(b)</enum>
        <header>GAO recommendations for inter-Agency coordination</header>
        <text>The <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="1127">Director</cato:entity-ref> shall ensure that the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-id="1127" entity-type="federal-body">Office of National Drug Control Policy</cato:entity-ref> takes into account the
			 report of the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-id="0500" entity-type="federal-body">Government Accountability Office</cato:entity-ref> entitled <quote>
            Office of National Drug Control Policy: Office Could Better Identify Opportunities to Increase
			 Program Coordination</quote> issued on March 26, 2013 (GAO–13–333), and identifies opportunities to enhance interagency
			 coordination as part of the Prescription Drug Abuse Prevention Plan, as
			 revised under <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Heroin and Prescription Opioid Abuse Prevention, Education, and Enforcement Act of 2014/s:6/ss:a" proposed="true">subsection (a)</cato:entity-ref>.</text>
      </subsection>
    </section>
    <section id="id0775A4C1907C4406AF5C114CEA467EF3">
      <enum>7.</enum>
      <header>Awareness campaigns</header>
      <subsection id="id4C1E64C2396C4CAD9F33557113A79D05">
        <enum>(a)</enum>
        <header>In general</header>
        <text display-inline="yes-display-inline">The <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-id="7500" entity-type="federal-body">Secretary of Health and Human Services</cato:entity-ref> shall advance the education and awareness of providers,
			 patients, and other appropriate
			 stakeholders regarding the risk of abuse of prescription opioid drugs if
			 such products are not taken as prescribed.</text>
      </subsection>
      <subsection id="id17F73FBF54514F19ACADE0D2BA465150">
        <enum>(b)</enum>
        <header>Drug-Free media campaign</header>
        <paragraph id="id47593B522A1D4334B7D2B979FE2479C7">
          <enum>(1)</enum>
          <header>In general</header>
          <text>The <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-id="1127" entity-type="federal-body">Office of National Drug Control Policy</cato:entity-ref>, in coordination with the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-id="7500" entity-type="federal-body">Secretary of Health and Human
			 Services</cato:entity-ref> and the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-id="1500" entity-type="federal-body">Attorney General</cato:entity-ref>, shall establish
			 a national drug awareness campaign.</text>
        </paragraph>
        <paragraph id="id0BFCA3031F1C4715B5FA930CD63A61BD">
          <enum>(2)</enum>
          <header>Requirements</header>
          <text>The national drug awareness campaign under <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Heroin and Prescription Opioid Abuse Prevention, Education, and Enforcement Act of 2014/s:7/ss:b/p:1" proposed="true">paragraph (1)</cato:entity-ref> shall—</text>
          <subparagraph id="idF87FA1104C16474ABE60C5DB791D9543">
            <enum>(A)</enum>
            <text>take into account the association between
			 prescription opioid abuse and heroin use; and</text>
          </subparagraph>
          <subparagraph id="idCCBC496B7025480CB1D6A1C8846C0F0A">
            <enum>(B)</enum>
            <text>emphasize
			 the similarities between heroin and prescription opioids and the effects
			 of heroin and prescription opioids on the human body.</text>
          </subparagraph>
        </paragraph>
        <paragraph id="id4E38F110590541698261E06A2FCB2467">
          <enum>(3)</enum>
          <header>Available funds</header>
          <text>Funds for the national drug awareness campaign may be derived from amounts appropriated to the
			 <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-id="1127" entity-type="federal-body">Office of National Drug Control Policy</cato:entity-ref> and otherwise available for
			 obligation and expenditure.</text>
        </paragraph>
      </subsection>
    </section>
  </legis-body>
</bill>
</doc>